home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next

Controlled Crystallization of Organic Compounds

  October 30, 2019  
CfPA-The Center for Professional Advancement, Edison, NJ or Virtually
March 12-13, 2020

Who Should Attend?
This course is intended for process chemists, chemical engineers, material scientists, project managers, consultants and other technical staffs responsible to ensure successful process development and/or production of organic compounds in pharmaceutical, food, fine chemical and cosmetics industries. Both experienced personnel and new-in-the-field can learn valuable knowledge and benefit from the course.

Course Description
Crystallization of organic compounds (such as drug substances, other active ingredients, and key intermediates) is a means used for isolation of specialty bulk products with desired quality attributes, in pharmaceutical, food, fine chemical and cosmetics industries. Control of crystallization processes is challenged commonly by both technical complexity and practical constraints. This course provides an intensive training on the fundamental principles, best practices and recent advances in this multi-disciplinary area, for solving real-world problems from early process development to product quality control in production. The basic concepts discussed in the class are related to the methods applied in process design, development and control, as well as trouble shooting. The topics in Course Outline will be discussed through a combination of lecture/discussion, use of case studies, Q&A, and problem-solving group exercises.
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Dr. Jian Wang, Consultant and Founder of the Center for Pharma Crystallization (CfPC)

Dr. Jian Wang is an expert in API crystallization, with comprehensive knowledge of the sciences and technologies required to meet challenging industrial needs. She has over 30 years of R&D experience, mainly in API crystallization and reaction engineering, and has been providing R&D services since 2005 to clients around the globe. Dr. Wang received her Ph.D. degree in Chemical Engineering in 1994, from the University of Pittsburg with Prof. Donna Blackmond and Prof. Irving Winder. During her 11-year tenure at Merck, Jian became an expert in API process R&D and a champion in implementing science based and technology-enabled approaches. She promoted directly the applications of PAT tools in process R&D serving as a consultant at Mettler Toledo AutoChem during 2005-2010. In 2011-2013, Jian took the responsibility as VP of Crystallization Development at Crystal Pharmatech, where she served a diverse client base. Starting in 2014, Jian started up a state-of-the-art crystallization lab and team at J-Star Research, which has grown into Center for Pharma Crystallization (CfPC) with top talents from leading pharma companies servicing the entire pharma industry. Dr. Wang has published 6 patents (5 related to API crystallization) and 20 peer-reviewed articles.
Deadline for Abstracts: N/A
Registration: Please click here for registration information.
E-mail: Jmorbit@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2020 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.